Molecular characterization of mucolipidosis: A case-series from Iran.
Mohadeseh Fathi, Sheyda Khalilian, Parvaneh Karimzadeh et al.
✦ AI-curated · Sources linked
Case in brief
Six unrelated Iranian patients with mucolipidosis underwent molecular characterization. Pathogenic homozygous variants were identified in GNPTAB, GNPTG, and MCOLN1, with all variants classified as pathogenic under ACMG guidelines and supported by ClinVar and gnomAD data. Two patients shared the GNPTAB variant c.3503_3504del (p.L1168Qfs*5). The report describes clinical and molecular features across mucolipidosis subtypes; the abstract does not provide individual presentations, diagnostic work-ups, or clinical outcomes.
What made this case unusual
Two unrelated cases carried the same homozygous GNPTAB frameshift variant, c.3503_3504del (p.L1168Qfs*5), among cases with variants across three mucolipidosis-associated genes.
Diagnostic / clinical pearl
Molecular testing can identify pathogenic variants across GNPTAB, GNPTG, and MCOLN1 and help characterize mucolipidosis subtypes; homozygous findings may be relevant when assessing consanguineous families.